A Pilot Study of Daptomycin for Antimicrobial Prophylaxis in Patients Undergoing Cardiac Valve Replacement and Coronary Artery Bypass Grafting (CABG) Who Are at Increased Risk for Infection Due to Methicillin-resistant Staphylococcus Aureus (MRSA)

Trial Profile

A Pilot Study of Daptomycin for Antimicrobial Prophylaxis in Patients Undergoing Cardiac Valve Replacement and Coronary Artery Bypass Grafting (CABG) Who Are at Increased Risk for Infection Due to Methicillin-resistant Staphylococcus Aureus (MRSA)

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 28 Aug 2015

At a glance

  • Drugs Daptomycin (Primary)
  • Indications Postoperative infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2008 Planned end date changed from 1 Jun 2009 to 1 May 2008.
    • 06 Nov 2008 Status changed from not yet recruiting to discontinued.
    • 04 Jan 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top